159 related articles for article (PubMed ID: 37558851)
1. Prognostic value of POD18 combined with improved IELSG in primary central nervous system lymphoma.
Du KX; Shen HR; Pan BH; Luthuli S; Wang L; Liang JH; Li Y; Yin H; Li JY; Wu JZ; Xu W
Clin Transl Oncol; 2024 Mar; 26(3):720-731. PubMed ID: 37558851
[TBL] [Abstract][Full Text] [Related]
2. Combined tumor-associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma.
Sun X; Wang C; Chen C; Huang J; Wu X; Wang Y; He X; Cao J; Jiang W; Sun P; Li Z
Hematol Oncol; 2021 Dec; 39(5):625-638. PubMed ID: 34543472
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial.
Joerger M; Huitema AD; Krähenbühl S; Schellens JH; Cerny T; Reni M; Zucca E; Cavalli F; Ferreri AJ
Br J Cancer; 2010 Feb; 102(4):673-7. PubMed ID: 20125159
[TBL] [Abstract][Full Text] [Related]
4. The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?
de Pádua Covas Lage LA; Araújo Soares V; Meneguin TD; Culler HF; Reichert CO; Jacomassi MD; Reis DGC; Zerbini MCN; de Oliveira Costa R; Rocha V; Pereira J
Radiat Oncol; 2022 Oct; 17(1):171. PubMed ID: 36273167
[TBL] [Abstract][Full Text] [Related]
5. A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma.
Liu CJ; Lin SY; Yang CF; Yeh CM; Kuan AS; Wang HY; Tsai CK; Gau JP; Hsiao LT; Chen PM; Liu YC; Hong YC; Ko PS; Liu JH; Lin CH
Cancer Med; 2020 Mar; 9(6):2134-2145. PubMed ID: 32011103
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Memorial Sloan-Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict Overall Survival in intracranial Primary CNS lymphoma.
Jahr G; Broi MD; Holte H; Beiske K; Meling TR
Brain Behav; 2018 Mar; 8(3):e00928. PubMed ID: 29541540
[TBL] [Abstract][Full Text] [Related]
7. MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma.
van der Meulen M; Dirven L; Bakunina K; van den Bent MJ; Issa S; Doorduijn JK; Bromberg JEC
J Neurooncol; 2021 Apr; 152(2):357-362. PubMed ID: 33611761
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein levels, the prognostic nutritional index, and the lactate dehydrogenase-to-lymphocyte ratio are important prognostic factors in primary central nervous system lymphoma: a single-center study of 223 patients.
Zuo J; Lei T; Zhong S; Zhou J; Liu R; Wu C; Li S
Neurosurg Rev; 2023 Dec; 47(1):17. PubMed ID: 38112846
[TBL] [Abstract][Full Text] [Related]
9. Clinical importance of Bcl-6-positive non-deep-site involvement in non-HIV-related primary central nervous system diffuse large B-cell lymphoma.
Song MK; Chung JS; Joo YD; Lee SM; Oh SY; Shin DH; Yun EY; Kim SG; Seol YM; Shin HJ; Choi YJ; Cho GJ
J Neurooncol; 2011 Sep; 104(3):825-31. PubMed ID: 21380743
[TBL] [Abstract][Full Text] [Related]
10. A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups.
Gao Y; Wei L; Kim SJ; Wang L; He Y; Zheng Y; Bertero L; Pellerino A; Cassoni P; Tamagnone L; Theresa PK; Deutsch A; Zhan H; Lai J; Wang Y; You H
Front Oncol; 2021; 11():696147. PubMed ID: 34422649
[TBL] [Abstract][Full Text] [Related]
11. Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patients.
Zeremski V; Adolph L; Beer S; Berisha M; Jacobs B; Kahl C; Koenecke C; Kropf S; Panse J; Petersen J; Schmidt-Hieber M; Schneider J; Vucinic V; Walter J; Weigert O; Witte HM; Mougiakakos D
Eur J Haematol; 2024 Apr; 112(4):641-649. PubMed ID: 38164819
[TBL] [Abstract][Full Text] [Related]
12. Primary central nervous system lymphoma: a profile of 26 cases from Western India.
Agarwal PA; Menon S; Smruti BK; Singhal BS
Neurol India; 2009; 57(6):756-63. PubMed ID: 20139505
[TBL] [Abstract][Full Text] [Related]
13. Primary central nervous system lymphoma: prognostication as per international extranodal lymphoma study group score and reactive CD3 collar.
Kumari N; Krishnani N; Rawat A; Agarwal V; Lal P
J Postgrad Med; 2009; 55(4):247-51. PubMed ID: 20083869
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Key Factors Associated with Response to Salvage High-Dose Methotrexate Rechallenge in Primary Central Nervous System Lymphoma with First Relapse.
Du P; Chen H; Shen L; Liu X; Wu X; Chen L; Cao A; Geng D
Curr Oncol; 2022 Sep; 29(9):6642-6656. PubMed ID: 36135091
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Features and Outcomes in Primary Central Nervous System Lymphoma: A 10-year Experience.
Puligundla CK; Bala S; Karnam AK; Gundeti S; Paul TR; Uppin MS; Maddali LS
Indian J Med Paediatr Oncol; 2017; 38(4):478-482. PubMed ID: 29333016
[TBL] [Abstract][Full Text] [Related]
16. Different patterns of failure in two treatment regimens for primary central nervous system lymphoma, a retrospective analysis of 124 cases in Taiwan.
Chuang CH; Kuo MC; Chang H; Wu JH; Hung YS; Ou CW; Lin TL; Su YJ; Ong YC; Shih LY; Kao HW
Clin Exp Med; 2023 Dec; 23(8):5327-5336. PubMed ID: 37679606
[TBL] [Abstract][Full Text] [Related]
17. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL).
Bergner N; Monsef I; Illerhaus G; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Nov; 11():CD009355. PubMed ID: 23152274
[TBL] [Abstract][Full Text] [Related]
18. Value of pretherapeutic DWI in evaluating prognosis and therapeutic effect in immunocompetent patients with primary central nervous system lymphoma given high-dose methotrexate-based chemotherapy: ADC-based assessment.
Zhang Y; Zhang Q; Wang XX; Deng XF; Zhu YZ
Clin Radiol; 2016 Oct; 71(10):1018-1029. PubMed ID: 27341986
[TBL] [Abstract][Full Text] [Related]
19. The role of upfront autologous stem cell transplantation in high-risk younger patients with primary central nervous system lymphoma.
Cho H; Chang JH; Kim YR; Kim SJ; Chung H; Park H; Lee JY; Jang JE; Kim Y; Kim SH; Yang WI; Suh CO; Cheong JW; Min YH; Kim JS
Br J Haematol; 2016 Aug; 174(3):444-53. PubMed ID: 27018207
[TBL] [Abstract][Full Text] [Related]
20. First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis.
Kasenda B; Ferreri AJ; Marturano E; Forst D; Bromberg J; Ghesquieres H; Ferlay C; Blay JY; Hoang-Xuan K; Pulczynski EJ; Fosså A; Okoshi Y; Chiba S; Fritsch K; Omuro A; O'Neill BP; Bairey O; Schandelmaier S; Gloy V; Bhatnagar N; Haug S; Rahner S; Batchelor TT; Illerhaus G; Briel M
Ann Oncol; 2015 Jul; 26(7):1305-13. PubMed ID: 25701456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
